http://www.crinetics.com
Crinetics Pharmaceuticals, Inc. Company Intro
About: Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. We have assembled a seasoned team with extensive expertise in drug discovery and development in endocrine G-protein coupled receptors (GPCRs) and built a highly productive drug discovery organization.
Industry
Healthcare
Crinetics Pharmaceuticals, Inc. Headquaters
Building No. 2
San Diego,92121
United States
Crinetics Pharmaceuticals, Inc. Share price
09 Apr 2021 01:27 GMT
$17.50
1.06 (6.45 %)
Crinetics Pharmaceuticals, Inc. Market cap
$591.217 M
WMC RANKING
2021
Crinetics Pharmaceuticals, Inc. # 261
BiotechnologyLatest Crinetics Pharmaceuticals, Inc. News
02 Apr 2021
Somatostatin Receptor Type 4 (SSTR4) Market Things to ...
... 4 (SSTR4) are profiled in the research publication such as Centrexion Therapeutics Corp, Strongbridge Biopharma plc and Crinetics Pharmaceuticals Inc. The ...
02 Apr 2021
Futuristics Overview of Polycystic Ovary Syndrome Drugs ...
... Sanofi, Addex Therapeutics Ltd., Teva Pharmaceutical Industries Limited, Merck ... Bristol Myers Squibb Co., AstraZeneca plc., Crinetics Pharmaceuticals, Inc ...
30 Mar 2021
Earnings Scheduled For March 30, 2021
Protalix BioTherapeutics, Inc. (DE) Common Stock (AMEX:PLX) is estimated to ... Crinetics Pharmaceuticals (NASDAQ:CRNX) is expected to report earnings for ...
WMC Market Score
WMC Market to Revenue Score
Crinetics Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Crinetics Pharmaceuticals, Inc. | USD | $1,193 | $55,025 | $-50,422 | $5,912M | 261 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $510,330B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,205,683 | $2,599,993 | $2,711,647 | $546,640B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,069,900 | $2,656,500 | $603,400 | $339,600B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $177,700B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Crinetics Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Crinetics Pharmaceuticals, Inc. | 0.02 | 2.20 | 0.49 | 0 | 0 | 0 | 1.35 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 0 | 0 | 0 | 100 |
| Incyte Corporation | 36.73 | 4.95 | 0.28 | 0 | 0 | 0 | 2.62 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
